IP Library Granted Patent US 8,962,311
Granted Patent B2
US 8,962,311 · App. 12/376,660 · Granted Feb 24, 2015

Method of obtaining chicken embryonic stem cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,962,311
App. No.
12/376,660
Granted
Feb 24, 2015
Kind
B2
Abstract

Method of culturing embryonic stem (ES) cells of avian origin includes the steps of: a) suspending ES cells originating from the blastoderm disk of fertilized un-incubated avian egg(s) in a basal culture medium supplemented with: insulin-like growth factor-1 (IGF-1) and ciliary neurotrophic factor (CNTF); and animal serum; and, optionally, at least one growth factor selected from among interleukin 6 (Il-6), interleukin 6 receptor (Il-6R), stem cell factor (SCF), fibroblast growth factor (FGF), leukemia inhibitory factor (LIF), interleukin 11 (Il-11), oncostatin and/or cardiotrophin; b) seeding the suspension of ES cells obtained in step a) on a layer of feeder cells and further culturing the ES cells for at least 2 to 10 passages; c) optionally, removing at least one growth factor selected from among SCF, FGF, Il-6, Il-6R, LIF, oncostatin, cardiotrophin and Il-11 from the culture medium; and d) further culturing the ES cells in the medium of step c) on a layer of feeder cells.

Claims (14)

1. A method of obtaining chicken embryonic stem (ES) cells comprising the steps of:

a) isolating and dissociating the blastoderm disk of fertilized un-incubated chicken embryos between development stages VI and XII;

b) culturing the cells obtained in step a) in a basal culture medium supplemented with IGF-1, CNTF, IL-6, IL-6R, SCF, and bFGF with a layer of feeder cells and animal serum; and

c) culturing the cells obtained in step b) in basal culture medium supplemented with IGF-1 and CNTF as the only supplemental growth factors with a layer of feeder cells and animal serum such that chicken ES cells are obtained.

2. The method according to claim 1 wherein the ES cells obtained in step d) are maintained in said culture medium for at least 14 days.

3. The method according to claim 1 wherein said feeder cells are mouse fibroblast cells.

4. The method according to claim 1 wherein the concentration of the growth factors IGF-1 and CNTF is about 1 ng/ml.

5. The method according to claim 1 wherein the ES cells obtained in step d) are maintained in said culture medium at 39° C. in 7.5% CO2.

6. The method according to claim 1 wherein said basal culture medium is selected from the group consisting of BME (basal Eagle Medium), MEM (minimum Eagle Medium), medium 199, DMEM (Dulbecco's modified Eagle Medium), GMEM (Glasgow modified Eagle medium), DMEM-HamF12, Ham-F12 and Ham-F10, Iscove's Modified Dulbecco's medium, MacCoy's 5A medium, RPMI 1640 and GTM-3 medium.

7. The method according to claim 1 wherein said basal culture medium is DMEM-HamF12.

8. The method according to claim 7 wherein said DMEM-HamF12 is complemented with 0.16 mM betamercaptoethanol, 1% non-essential amino acids, 1 mM sodium pyruvate, and 2 mM L-Glutamine.

9. The method according to claim 1 wherein said basal culture medium is DMEM-HamF12 supplemented with 10% fetal calf serum, 0.16 mM betamercaptoethanol, 1% non-essential amino acids, 1 mM sodium pyruvate, 2 mM L-Glutamine, 1 ng/ml IGF-1, 1 ng/ml CNTF and 1% penistreptomycine.

10. The method according to claim 1 wherein said chicken embryos are fertilized un-incubated chicken embryos at development stage X.

11. The method according to claim 1 , wherein in step b) cells are cultured for at least between 2 to 10 passages.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: VALNEVA AUSTRIA GMBH; VALNEVA SE; VALNEVA USA, INC.
Reel/Frame 073516/0522 →
PATENT SECURITY AGREEMENT Recorded Oct 20, 2025
From: VALNEVA AUSTRIA GMBH; VALNEVA SE; VALNEVA SWEDEN AB
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 073164/0032 →
SECURITY INTEREST Recorded Mar 4, 2020
From: VALNEVA SE; VALNEVA USA, INC.; VALNEVA AUSTRIA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052016/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2014
From: GUEHENNEUX, FABIENNE
To: VALNEVA
Reel/Frame 033697/0396 →
CHANGE OF NAME Recorded Jan 24, 2014
From: VIVALIS
To: VALNEVA
Reel/Frame 032036/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2010
From: VALARCHE, ISABELLE; BATARD, LUC; MEHTALI, MAJID
To: VIVALIS
Reel/Frame 024264/0067 →